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Abstract
As obese and overweight patients commonly display hyperlipidemia and are increasingly accessing fertility clinics for their
conception needs, our studies are directed at understanding the effects of hyperlipidemia on early pregnancy. We have focused on
investigating palmitic acid (PA) and oleic acid (OA) treatment alone and in combination from the mouse two-cell stage embryos as a
model for understanding their effects on the mammalian preimplantation embryo. We recently reported that PA exerts a negative
effect on mouse two-cell progression to the blastocyst stage, whereas OA co-treatment reverses that negative effect. In the present
study, we hypothesized that PA treatment of mouse embryos would disrupt proper localization of cell fate determining and blastocyst
formation gene products and that co-treatment with OA would reverse these effects. Our results demonstrate that PA treatment
significantly (P < 0.05) reduces blastocyst development and cell number but did not prevent nuclear localization of YAP in outer
cells. PA treatment significantly reduced the number of OCT4+ and CDX2+ nuclei. PA-treated embryos had lower expression of
blastocyst formation proteins (E-cadherin, ZO-1 and Na/K-ATPase alpha1 subunit). Importantly, co-treatment of embryos with OA
reversed PA-induced effects on blastocyst development and increased inner cell mass (ICM) and trophectoderm (TE) cell numbers and
expression of blastocyst formation proteins. Our findings demonstrate that PA treatment does not impede cell fate gene localization
but does disrupt proper blastocyst formation gene localization during mouse preimplantation development. OA treatment is
protective and reverses PA’s detrimental effects. The results advance our understanding of the impact of FFA exposure on mammalian
preimplantation development.
Reproduction (2022) 163 133–143

Introduction
The World Health Organization defines obesity as a
BMI of 30 kg/m2 or greater (WHO 2000) and obesity
is reaching epidemic proportions. The incidence of
diabetes, hypertension, heart disease and high serum
cholesterol demonstrates a graded increase as BMI
rises (Paeratakul et al. 2002, Knight et al. 2010). Obese
females face many challenges including menstrual
irregularity, endometrial pathologies, higher miscarriage
rates and infertility (Broughton & Moley 2017). As
BMI increases, women experience increased time-topregnancy and overall decreased fecundity (Wise et al.
2010). Furthermore, when obese women conceive, their
pregnancies have increased incidence of preterm birth,
high- and low-birth weight infants, increased risk of
congenital anomalies (Knight et al. 2010, Schummers
et al. 2015, Stang & Huffman 2016), pre-eclampsia and
gestational diabetes (Stang & Huffman 2016). Assisted
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reproductive technologies (ARTs) are increasingly being
required to achieve successful pregnancy in sub-fertile
obese couples. Increasing BMI is positively correlated
with pregnancy loss following ART treatment (Fedorcsák
et al. 2004).
Obesity is accompanied by increased serum (Gaudet
et al. 2012) and follicular fluid palmitic acid (PA) levels
(Niu et al. 2014, Valckx et al. 2014). PA is a 16-carbon
fully saturated fatty acid that increases the synthesis of
harmful lipids and impedes normal organelle functioning
(Yuzefovych et al. 2010, Palomer et al. 2018). It is the
most abundantly saturated fatty acid in the human
body (Carta et al. 2017). PA is present in many foods
including meat, dairy and palm oil (Carta et al. 2017).
The dysregulation of PA levels has detrimental longterm effects such as atherosclerosis, neurodegenerative
disorders and cancer (Fatima et al. 2019).
Oleic acid (OA) is an 18-carbon fatty acid with a single
double bond (Lopez et al. 2014). It is the most abundant
This work is licensed under a Creative Commons
Attribution 4.0 International License.
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unsaturated fatty acid in human plasma (Palomer et al.
2018). OA can be obtained in the human diet through
olive, canola and peanut oils (Lopez et al. 2014) and is
a primary component of the Mediterranean diet which
lessens disease incidence such as diabetes (MartınezGonzalez et al. 2008). OA decreases PA-induced
apoptosis and ROS (Yuzefovych et al. 2010), decreases
PA-induced inflammation and relieves ER stress
(Palomer et al. 2018). We have recently reported that
PA treatment reduces mouse blastocyst development in
a concentration-dependent manner and alters ER stress
pathway transcript levels, while co-treatment of OA with
PA reversed these negative effects (Yousif et al. 2020).
Interestingly, we observed a small percentage of PA (100
µM) treated two-cell stage embryos that still cavitate, but
for this study, we were especially interested in those that
were unable to cavitate and become blastocysts.
Mammalian
preimplantation
development
is
characterized by a series of cleavage cell divisions from
fertilized oocyte to multi-cellular blastocyst (Watson
& Barcroft 2001). The initial cleavages occur without
concomitant embryo growth (Hardy et al. 1993), and
eventually the cells compact and form a morula (Watson
& Barcroft 2001, Pfeffer 2018). At the mouse 32-cell
stage, a cavity begins to form, leading to the blastocyst
stage and the specification of two distinct cell lineages:
the TE and ICM (Watson & Barcroft 2001, Niwa et al.
2005).
OCT4 (POU5F1)is a pluripotency cell factor that
gradually becomes restricted to the mouse ICM, acting to
regulate transcription of target genes and maintain ICM
pluripotency (Nichols et al. 1998). CDX2 is expressed
in all cells at the 8-cell stage and gradually becomes
restricted to the future trophectoderm in the blastocyst
(Niwa et al. 2005). CDX2-deficient embryos have a
poorly formed TE with deficiencies in maintaining tight
junctions (Strumpf et al. 2005). OCT4 is downregulated
when CDX2 reaches a specific threshold in mouse
outer cells and collectively this asymmetry in cell
lineage expression drives the formation of the ICM and
TE (Niwa et al. 2005). CDX2 expression is induced by
the transcription factor TEAD4 (Nishioka et al. 2009)
and also requires Hippo pathway member YAP (Ota &
Sasaki 2008). Failure to properly generate the first cell
lineages can prevent the initiation of pregnancy (Piliszek
et al. 2016).
Blastocyst development depends on the timely
expression of critical gene families including: E-cadherin–
catenin cell adhesion genes, the tight junction genes and
Na/K-ATPase subunits (reviewed in Watson & Barcroft
2001, Bell et al. 2008). Na/K-ATPase develops the ionic
gradient which drives the movement of water through
aquaporins across the epithelium to form the fluid-filled
blastocyst cavity (Watson & Barcroft 2001). The cell-tocell adhesion provided by E-cadherin–catenin and tight
junctional proteins such as ZO-1 inhibits the leakage
of blastocyst fluid and maintains a polarized Na+/K+Reproduction
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ATPase distribution (Watson & Barcroft 2001). These
events are interconnected, as interrupting expression or
activity of Na/K-ATPase in embryos affects localization
of ZO-1 (Violette et al. 2006, Madan et al. 2007).
Because of the many fertility challenges obese
women face and the importance of preimplantation
development to successful pregnancy (Knight et al.
2010), we have pursued an understanding of how
preimplantation development may be affected by PA
and OA exposure. To date, research has not explored
the effects of PA and OA on cell fate gene product and
blastocyst formation gene product localization during
preimplantation development. The primary objective
was to determine how PA and OA treatment, alone
and in combination, will affect YAP, OCT4, CDX2,
Na/K ATPase α-1, E-cadherin and ZO-1 localization
in mouse preimplantation embryos. We hypothesized
that PA treatment of mouse preimplantation embryos
would disrupt normal cell fate gene product and
blastocyst formation gene product localization and
that co-treatment with OA would reverse these effects.
Our findings demonstrate that PA treatment does not
impede cell fate gene product localization but reduces
cell margin localization of blastocyst formation proteins.
OA co-treatment reverses these effects of PA treatment.
The results advance our understanding of the possible
impact of obesity and FFA exposure on mammalian
preimplantation development.

Materials and methods
Animal source and ethics approval
CD1 mice were acquired from Charles River Canada (SaintConstant, Quebec, Canada). The mice had free access to food
and water while being housed in 12 h light: 12 h darkness
cycles. All mice were handled according to the Canadian
Council on Animal Care and Western University’s Animal
Care and Use Policies (protocol #: 2018-075 to Dr Andrew J.
Watson).

Mouse superovulation and mating
Four- to six-week-old female CD-1 mice received a 5–7.5
international units (IU) intraperitoneal (i.p.) injection with
pregnant mare’s serum gonadotropin (Folligon, Merck Animal
Health, Canada). This was followed by a 5–7.5 IU i.p. injection
of human chorionic gonadotrophin (Chorulon, Merck) 46–48
h later. Following the second injection, each female was
placed in a cage with a single male CD-1 mouse (3–8 months
of age) for mating overnight. The following morning, female
mice were checked for presence of a seminal plug. Forty-six
hours post-injection of hCG, female mice were sacrificed
by CO2 asphyxiation (standard operating procedure). Their
oviducts were collected and flushed with M2 flushing medium
(Sigma–Aldrich). Flushed two-cell stage embryos were
washed 3× in 50 μL drops of potassium simplex optimization
medium with amino acids (KSOMaa Evolve, Zenith Biotech,
https://rep.bioscientifica.com
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Canada) for OCT4/CDX2 and cell counting experiments.
Due to discontinuation of this product, YAP, Na/K ATPase α1, E-cadherin and ZO-1experiments were conducted with
KSOM+AA (IVL04, Caisson Laboratories, Smithfield, UT).
After washing, embryos were distributed equally among
experimental treatment groups and cultured in 20 μL drops
under mineral oil (LiteOil LGOL-500, Cooper Surgical,
Trumbull, CT) at a density of 1 embryo per μL for 46 h under a
5% CO2, 5% O2 and 90% N2 culture atmosphere.

Free-fatty acid (FFA) preparation and embryo culture
A 20% FFA-free BSA (A6003, Sigma) was prepared in PBS,
filter sterilized and used to conjugate with PA (P0500, Sigma)
or OA (75090, Sigma) as outlined in Alsabeeh et al. (2018).
Stock PA and OA solutions were prepared by solubilizing
each FFA in RNAse-free water and NaOH at 70°C to create
a 20 mM solution that was stored at −20°C. This stock was
heated to 70°C and conjugated in a 1:3 (v/v) ratio with 20%
BSA initially, followed by a dilution to 500 µM FFA solution
in KSOM that was filtered and stored at 4°C. This results
in a 2:1 molar ratio of PA or OA to BSA. The BSA control
had a similar amount of added NaOH. All treatment
groups thus contained 0.6% added fatty acid-free BSA final
concentration.

PA and OA concentration response and treatment
experiments
PA and OA treatment concentrations were derived from
concentration responsive experiments conducted and
reported in our recent study (Yousif et al. 2020); 100 µM PA
had a negative effect on blastocyst development and 100
µM OA was able to overcome these deficits. PA is in the low
physiological range, as 300–400 µM PA was measured in the
regular chow-fed mouse oviduct (Yousif et al. 2020). Third
trimester women with normal glucose tolerance had serum
levels of 122 µM PA and 83 µM OA (Chen et al. 2010) which
increased in obese women with gestational diabetes to 151
and 104 µM, respectively. For each experimental replicate,
treatment groups consisted of 2- to 4-cell stage mouse
embryos randomly allocated to the following treatments:
(1) control KSOMaa medium (120 μL BSA control in a total
volume of 300 μL balance KSOM); (2) KSOMaa medium +100
μM PA (60 μL + 60 μL BSA control in 300 μL); 3) KSOMaa
medium + 100 µM OA (60 μL + 60 μL BSA control in 300 μL)
and 4) KSOMaa + 100 µM PA (60 μL) and 100 µM OA (60 μL in
300 μL). Embryos were cultured under a 5% CO2, 5% O2 and
90% N2 atmosphere at 37°C for 46 h to assess progression to
the blastocyst stage. Blastocysts were defined as embryos with
a visible fluid-filled cavity of any size and the proportion was
calculated based on number of two-cell cultured. Following
this assessment, embryos were fixed for application of indirect
immunofluorescence localization of OCT4, CDX2, YAP,
Na/K-ATPase ∝ 1 subunit, ZO-1 or E-cadherin combined
with 4,6-diamindino-2-phenylindole (DAPI) nuclear staining,
actin cytoskeleton staining with rhodamine phalloidin and
confocal microscopy.
https://rep.bioscientifica.com
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Immunofluorescence and confocal microscopy
Following culture, embryos in each treatment were fixed and
permeabilized in 2% paraformaldehyde in PBS for 30 min.
Embryos were stored in PIPES/HEPES/EGTA and MgCl2 (PHEM,
Schliwa & van Blerkom 1981) buffer at 4°C before staining.
The preimplantation embryos were then blocked in 5% normal
donkey serum (Jackson ImmunoResearch) with 0.01% Triton
X-100 in PBS for at least 1 h at room temperature. Embryos
were washed once in PBS. Then primary antibodies were added
to antibody dilution buffer (ADB) consisting of PBS containing
0.5% normal donkey serum and 0.005% Triton-X and incubated
overnight at 4°C. Antibodies included (1) mouse anti-YAP (sc101199, Santa Cruz Biotechnology) diluted (1:100), (2) mouse
anti-OCT3/4 (C-10, sc-5279, 1:50 Santa Cruz), (3) rabbit antiCDX2 (ab76541, 1:100; Abcam), (4) rabbit anti-E-cadherin
(#3195, Cell Signaling) or (5) rat anti-ZO1 (MABT11, EMD
Millipore), diluted in ADB. Rabbit-sodium potassium ATPase
alpha1 subunit antibody (ab237969, 1:100, Abcam) staining
was performed completely in PHEM buffer (Betts et al. 1998).
Donkey anti-mouse Alexa Fluor 488- (715-545-151, Jackson
ImmunoResearch), donkey anti-rabbit fluorescein (711-095152, Jackson), donkey anti-rat fluorescein (712-095-153,
Jackson) or donkey anti-rabbit Alexa Fluor 555-conjugated
secondary antibodies (A31572, Thermo Fisher Scientific)
were added and incubated at 4°C overnight. Embryos were
counterstained with final 1:1000 dilution of 1 mg/mL stock
solution DAPI (D9542, Sigma) to stain all nuclei blue and 1:20
final dilution of 5 µg/mL stock solution of rhodamine phalloidin
(P1951, Sigma) to stain the actin cytoskeleton red for 1 h at
37°C. Processed embryos were mounted on glass bottom
dishes in drops of KSOMaa and covered with mineral oil
(Sigma) to prepare for confocal imaging. Confocal microscopy
was performed using a Zeiss LSM800 laser scanning confocal
microscope (Carl Zeiss Microscopy). Increments of 5 µm were
used to produce a Z-stack for each embryo. Laser strength
settings were consistent between groups within a replicate.
Z-stacks were saved as CZI files on Zen imaging program
(Zeiss). Using the cell counter function, OCT4, CDX2, YAP
and DAPI total nuclei were quantified manually in FIJI (open
source softeare ImageJ available at https://imagej.net/software/
fiji/). Nuclei were counted as positive if they had fluorescence
substantially above cytoplasmic levels, cells that were dividing
had increased cytoplasmic staining for OCT4 and were not
counted as positive.

Quantitation of Na+/K+ ATPase alpha1 subunit,
E-cadherin and ZO1 fluorescence intensity
Na+/K+ ATPase alpha1 subunit, E-cadherin and ZO-1
fluorescence intensity were quantified using Zen and Ilastik
(www.ilastik.org). From the embryo group Z-stacks czi files
taken at 10×, rectangular boxes were drawn around individual
embryos and the entire stack of green channel was converted
to a TIFF file. In Ilastik, a single bright embryo slice was
chosen in each replicate experiment, and the foreground and
background fluorescence were delineated. All the other TIFF
files were then imported and calibrated against this standard.
For each embryo, all tissue slices were summed from 16 to
Reproduction (2022) 163 133–143
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18 5 µm Z-stack slices to give an individual embryo value.
The average fluorescence of the negative control embryos
was subtracted, embryos that had lower fluorescence than
the negative were set to 0. For each antibody, there were
at least two (OCT4 and CDX2), three (YAP, Na+/K+ ATPase
alpha1 subunit or E-cadherin) or four (ZO-1) different embryo
collections subjected to separate staining and quantification
protocols. There was a minimum of 22 to a maximum of 68
embryos evaluated per treatment.

Statistical analysis
GraphPad
PRISM
(https://www.graphpad.com/scientificsoftware/prism/) was employed to perform statistical analyses.
For cell fate protein localization studies, each embryo
examined represented a single n value within a treatment.
However, for assessments of developmental stage, a biological
replicate consisted of a single pool of embryos within a
treatment group. Blastocyst development was analyzed using
a one-way ANOVA test, and means were compared to one
another by an ad hoc Tukey’s multiple comparisons test. Data
analysis for DAPI-, OCT4-, CDX2- and YAP-positive nuclei
included applying Kruskal–Wallis non-parametric ANOVA (as
values were not normally distributed) with Dunn’s multiple
comparisons tests. Data analysis of Na+/K+ ATPase, ZO-1
and E-cadherin fluorescence intensity was performed with
non-parametric Kruskal–Wallis ANOVA with Dunn’s multiple
comparisons tests. For all tests, P values of less than or equal to
0.05 were considered significantly different from one another.

Results
PA alone reduces blastocyst formation and total cell
number while development is restored in combination
with OA development
Preimplantation embryos from each treatment group
were assessed using conventional light microscopy.
Blastocysts were identified as having fluid-filled cavities
(Fig. 1A) and were quantified as a percentage of all
preimplantation embryos observed in each culture
treatment group (Fig. 1C). A statistically significant
decrease (P < 0.001) in the number of blastocysts
was observed in the PA-treated group compared to
all other groups (Fig. 1C), which is consistent with
our previous study (Yousif et al. 2020). There were no
significant differences in blastocyst developmental
frequency between the control, OA alone and PA and
OA combination (PA/OA) treatment groups (Fig. 1C).
We assessed the total number of DAPI-stained nuclei
observed in each embryo composing each treatment
group (Fig. 1B and D). PA-treated embryos displayed
a significant reduction (P < 0.001) in total number
of nuclei compared to all other treatment groups and
control group (Fig. 1D). PA/OA had lower cell number
than control (P < 0.04, Fig. 1D). The majority of
PA-treated embryos appeared as uncompacted cleavage
Reproduction
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Figure 1 Representative phase contrast and DAPI-stained images from
each treatment group. Brightfield (A) and confocal microscopy of
preimplantation embryos imaged at 40× and stained with (B) DAPI
(blue). (a) Control embryo, (b) PA-treated embryo, (c) OA-treated
embryo and (d) PA and OA combination-treated embryo. Scale
bars = 20 µm. (C) Data represent the mean percentage of blastocysts
±s.e.(n =20, s.e.m.). (D) The mean cell numbers ± s.e.m. observed for
each treatment group. Groups that do not share the same letter are
significantly different, P < 0.05. (A, B, D) Control embryos (n = 5
experimental replicates, 9–13 embryos per replicate), PA-treated
embryos (n = 5, 11–36 embryos per replicate), OA-treated embryos
(n = 5, 13–21 embryos per replicate) and PA and OA combinationtreated embryos (n = 5, 7–19 embryos per replicate).

stage embryos (Fig. 2Ab). The mean cell number of the
PA-treated group was approximately 21 cells.
Effects of PA and OA treatment alone and in
combination of YAP+ nuclei
The number of cells with YAP localized to the nucleus
following each treatment was counted (Fig. 2A and C).
The presence of binucleate cells in the PA-treated group
was commonly observed (Fig. 2Ab and Bb). Some YAP+
and YAP− cells were binucleate; however, cells with YAPnuclei were properly localized to the inside. PA-treated
embryos displayed a significantly (P < 0.0001) lower
number of YAP+ nuclei compared to all other treatment
groups (Fig. 2C). Interestingly, the proportion of YAP+
nuclei to total nuclei did not vary significantly (P > 0.05)
between the control, PA and OA treatment groups (Fig.
2D). The proportion of YAP+ nuclei to total cell nuclei in
the PA and OA combination treatment was significantly
(P < 0.05) higher than that observed for the control, OA
and PA alone treatments (Fig. 2D).
PA reduced the number of OCT4+ nuclei, while OA in
combination with PA restored OCT4+ number
PA-treated embryos displayed a significantly lower
(P < 0.0001) number of OCT4+ nuclei compared to the
vehicle-treated control group and other treatment groups
https://rep.bioscientifica.com
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and lower than the combined PA/OA group (P < 0.005,
Fig. 3G). Control, OA and PA/OA treatments were not
significantly different from each other.
PA reduced the amount of Na+/K+-ATPase α-1 subunit,
E-cadherin and ZO-1 membrane localization
The level of Na+/K+-ATPase fluorescence intensity in
PA-treated embryos was significantly lower (P < 0.005)
compared to CON and P < 0.02 for both OA and PA/OA
(Fig. 4A, B and C). The level of E-cadherin fluorescence
intensity was significantly lower (P < 0.02) in PA-treated
embryos compared to the OA group (Fig. 5A, B and
C). The level of ZO-1 fluorescence intensity was also
significantly lower (P < 0.004) in PA-treated embryos
compared to the CON group (Fig. 6A, B and C).

Discussion
Figure 2 Representative YAP immunofluorescence images from each
treatment group. OA attenuates the PA-induced decrease in number
of cells expressing nuclear YAP. Representative confocal microscopy
images of preimplantation embryos imaged at 40× following
processing for indirect immunofluorescence (A) YAP (green), (B)
rhodamine phalloidin (F-actin, red), DAPI (blue) representative
merged images. (a) Control embryo, (b) PA-treated embryo, (c)
OA-treated embryo and (d) PA and OA combination-treated embryo.
Scale bars = 20 µm. PA-treated embryos frequently demonstrated
binucleate cells. White arrow demonstrates binucleate cell with YAP+
nuclei, while blue arrowhead shows a cell with binucleate YAPnuclei. Control (n = 3 experimental replicates, 8–16 embryos per
replicate), PA treated (n = 3, 11–19 embryos per replicate), OA
treated (n = 3, 13–15 embryos per replicate) and PA and OA
co-treated preimplantation embryos (n = 3, 7–15 embryos per
replicate). (C) Data shown represent the value of the individual
embryos and mean number of cells with nuclear YAP ± s.e.m. in each
embryo for each treatment group. (D) The value of the individual
embryos and the mean proportion of nuclear YAP+ cells ± s.e.m. of
total cells in all embryos in each treatment. Groups that do not share
the same letters are significantly different, P < 0.05.

(Fig. 3Ab and D). The mean proportion of OCT4+ nuclei
in the control, OA and PA/OA embryos was significantly
greater than the PA-treated embryos (P < 0.0001). The
proportion of OCT4+ nuclei in OA-treated embryos
(P < 0.005) and PA and OA combination-treated embryos
(P < 0.004) was lower than control embryos (Fig. 3E).
There was no significant difference in the proportion
of OCT4+ nuclei between OA- and PA/OA-treated
embryos (Fig. 3E).
PA reduced the number of CDX2+ nuclei, while OA in
combination with PA restored CDX2+ cell number
The number of CDX2+ nuclei in the PA-treated embryos
was significantly lower (P < 0.0001) compared to all
other groups (Fig. 3Bb and F). The mean proportion of
CDX2+ cells in PA-treated group was significantly lower
(P < 0.0001) than the control and OA treatment groups
https://rep.bioscientifica.com

Treatment of mouse embryos with PA resulted in impaired
development similar to previous studies (Jungheim et al.
2011a, Yousif et al. 2020). The concentrations of PA and
OA used are like those of serum levels in normal pregnant
women of about 100 µM (Chen et al. 2010), but PA can
increase 30–60% in serum and follicular fluid in obese
patients (Jungheim et al. 2011b, Valckx et al. 2014).
Cleavage (O’Gorman et al. 2013) and pregnancy (Mirabi
et al. 2017) in ART cycles are negatively correlated with
follicular fluid PA concentrations. In the embryos treated
with 100 µM PA, the cell number averaged 21 cells,
many embryos arrested at the 8–16 cell stage and 22%
developed to the blastocyst stage. Short-term exposure of
mammalian female gametes to PA showed long-lasting
effects, as development was delayed (Desmet et al.
2020) and fetuses and liveborn animals were smaller
following embryo transfer (Jungheim et al. 2011a). As
well, gene expression was altered in both embryo and
extra-embryonic tissue (Desmet et al. 2020). ER stress
pathways are activated in mammalian female gametes
and granulosa cells subjected to PA treatment in vitro
(Wu et al. 2012, Yousif et al. 2020).
We observed that PA-treated embryos developed
multi-nuclear cells. Multi-nuclear blastomeres in
human embryos are quite common (Hardy et al. 1993),
but they are rare in cultured CD1 mouse embryos. In
human embryos, multi-nucleation is associated with
aneuploidies (Staessen & Van Steirteghem 1998).
However, binucleation can resolve if it occurs at the
two-cell stage (Aguilar et al. 2016, Paim & FitzHarris
2020) but not later (Paim & FitzHarris 2019). Paim and
FitzHarris (2020) suggest that binucleate cells in later
stage mouse embryos arise due to a failure of cytokinesis,
as was observed earlier in arrested human embryos
(Hardy et al. 1993). Zhang et al. (2010) demonstrated
that PA treatment resulted in the formation of binuclear
HeLa cells due to disrupted cytokinesis. Difficulties
in completing cytokinesis may underlie the reduced
Reproduction (2022) 163 133–143
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Figure 3 Representative OCT4 and CDX2 immunofluorescence images and quantification. Confocal microscopy images of preimplantation
embryos imaged at 40× following processing for indirect immunofluorescence (A) OCT4 (green), (B) CDX2 (red), (C) merged representative
OCT4 and CDX2 images. (a) Control embryo, (b) PA-treated embryo, (c) OA-treated embryo and (d) PA and OA combination-treated embryo.
Scale bars = 20 µm. At early blastocyst stage, some outer nuclei still co-express OCT4 and CDX2 (yellow to orange staining), blue arrowheads.
(D) Data shown represent the value of the individual embryos and the mean total OCT4+ nuclei ± s.e.m. for each treatment group. (E) The mean
proportion of OCT4+ nuclei ± s.e.m. of total cells in each treatment. (F) Data shown represent the mean total CDX2+ nuclei ± s.e.m. for each
treatment group. (G) The mean proportion of CDX2+ nuclei ± s.e.m. of total cells in each treatment. Groups that do not share the same letters are
significantly different, P < 0.05. Control embryos (n = 2 experimental replicates, 10–12 embryos per replicate), PA-treated embryos (n = 2,
18–36 embryos per replicate), OA-treated embryos (n = 2, 17–20 embryos per replicate) and PA and OA combination-treated embryos (n = 2,
17–19 embryos per replicate).

Figure 4 Representative Na+/K+ ATPase α-1 immunofluorescence images from each treatment group. Confocal microscopy images of
preimplantation embryos imaged at 40× following processing for indirect immunofluorescence (A) Na+/K+ ATPase α-1 subunit (green), F-actin
(red), DAPI (blue), merged images on left panel and Na+/K+ ATPase α-1 subunit alone on right panel. (a) Control embryo, (b) PA-treated embryo,
(c) OA-treated embryo and (d) PA and OA combination-treated embryo. Scale bars = 20 µm. (B) Embryo group photo of Na+/K+ ATPase α-1
(green), 10× magnification, (C) quantification of Na+/K+ ATPase α-1 intensity in each treatment group. Data shown represent the values of the
individual embryos and the mean Na+/K+ ATPase α-1 fluorescence ± s.e.m. for each treatment group. Bars without letters in common are
significantly different, P < 0.05. Control embryos (n = 3 experimental replicates, 13–16 embryos per replicate), PA-treated embryos (n = 3,
12–21 embryos per replicate), OA-treated embryos (n =3, 12–15 embryos per replicate) and PA and OA combination-treated embryos (n = 3,
14–15 embryos per replicate).
Reproduction
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Figure 5 Representative E-cadherin immunofluorescence images from each treatment group. Confocal microscopy images of preimplantation
embryos imaged at 40× following processing for indirect immunofluorescence (A) E-cadherin (green), F-actin (red), DAPI (blue), merged images
on left panel and E-cadherin alone on right panel. (a) Control embryo, (b) PA-treated embryo, (c) OA-treated embryo and (d) PA and OA
combination-treated embryo. Scale bars = 20 µm. (B) Embryo group photo of E-cadherin (green), 10× magnification (a) Control embryo, (b)
PA-treated embryo, (c) OA-treated embryo and (d) PA and OA combination-treated embryo. (C) Quantification of E-cadherin intensity in each
treatment group. Data shown represent the values of the individual embryos and the mean E-cadherin fluorescence ± s.e.m. for each treatment
group. Bars without letters in common are significantly different, P < 0.05. Control embryos (n = 3 experimental replicates, 15–20 embryos per
replicate), PA-treated embryos (n = 3, 17–19 embryos per replicate), OA-treated embryos (n =3, 12–20 embryos per replicate) and PA and OA
combination-treated embryos (n = 3, 14–18 embryos per replicate).

Figure 6 Representative ZO-1 images from each treatment group. Confocal microscopy images of preimplantation embryos imaged at 40×
following processing for indirect immunofluorescence (A) ZO-1 subunit (green), F-actin (red), DAPI (blue), merged images on left panel, ZO-1
alone on right panel. (a) Control embryo, (b) PA-treated embryo, (c) OA-treated embryo and (d) PA and OA combination-treated embryo. Scale
bars = 20 µm. (B) Embryo group photo of ZO-1 (green), 10× magnification. (C) Quantification of ZO-1 intensity in each treatment group. Data
shown represent the values of the individual embryos and the mean ZO-1 fluorescence ± s.e.m. for each treatment group. Bars without letters in
common are significantly different, P < 0.05. Control embryos (n = 4 experimental replicates, 11–18 embryos per replicate), PA-treated embryos
(n = 4, 10–24 embryos per replicate), OA-treated embryos (n = 4, 13–16 embryos per replicate) and PA and OA combination-treated embryos
(n = 4, 13–16 embryos per replicate).
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cell numbers of the PA treatment group in the present
study. Further studies are required to determine whether
this is the case and when binucleation is occurring in
PA-treated 2-cell embryos.
While we have an excellent understanding of the
basic mechanisms and molecular players involved
in cell lineage specification in mammalian embryos,
there is more to learn about governing mechanisms
that coordinate the timing of cell fate events and their
sequence (Piliszek et al. 2016). Early blastomeres
transition from totipotency to obtaining positional
information (outside or inside cells), triggering
polarization, adherens junction cell to cell adhesion,
and compaction leading to epithelialization and
differentiation of TE cells (Piliszek et al. 2016). The
role of the Hippo pathway in TE differentiation is to
differentially regulate YAP phosphorylation in TE and
ICM development (Nishioka et al. 2009, Anani et al.
2014, Sasaki 2017). Normally following compaction
at the 8-cell stage, each blastomere acquires polarity
(Johnson et al. 1986). At the 16-cell stage, nuclear YAP
is expressed in the outer cells, controlled mainly by
blastomeres inheriting apical membrane components
(Anani et al. 2014, Hirate et al. 2015, Sasaki 2017).
In the outer cells, i.e. TE progenitors, Hippo activity is
inactivated thus allowing YAP to localize to the nucleus
and interact with TEA domain transcription factor (TEAD)
resulting in CDX2 expression and TE cell differentiation
(Nishioka et al. 2009, Anani et al. 2014, Sasaki 2017). In
contrast, the Hippo pathway is active in the ICM which
results in phosphorylated YAP that remains cytoplasmic
(Nishioka et al. 2009, Anani et al. 2014, Sasaki 2017).
By the 32-cell stage, differential activation of Hippo
signaling in the two-cell lineages is cemented by the
formation of stable E-cadherin-mediated adherens
junctions (Nishioka et al. 2009, Anani et al. 2014,
Sasaki 2017). PA-treated embryos were predominantly
8–16-cells; still, YAP immunofluorescence localization
appeared to be correct for regulating cell fate in outer
cells, i.e. nuclear in outer cells. The proper localization
of YAP may indicate that PA treatment did not alter
membrane structure or domain inheritance. Since they
are chronological at a normal developmental time point
for these mechanisms to reveal themselves, we suggest
that the PA-treated embryos were simply activating a
normal cell fate developmental program according to
the polar or apolar status of the blastomeres to the best
of their ability.
The number of YAP+ nuclei was lower in the PA
group in comparison to other groups; however, the
proportion of YAP+ nuclei was unaffected. PA embryos
including cleavage stage embryos displayed nuclear YAP
immunofluorescence. Other studies have found that PA
reduced the number of endothelial cells with nuclear
YAP (Yuan et al. 2017); however, studies with β-cell
lines have shown that PA induced nuclear localization
Reproduction
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of YAP (Deng et al. 2016). Inhibition of YAP resulted in
increased PA-induced apoptosis, suggesting that nuclear
YAP may have a protective role in β-cells (Deng et al.
2016). Since, the proportion of YAP+ nuclei did not vary
significantly between PA and control groups, we would
propose that cell lineage specification mechanisms
were activated, but for the majority of PA-treated
embryos, this was not sufficient to enable cavitation and
blastocyst formation.
We observed lower numbers and proportion of
OCT4+ cells in PA-treated embryos, which is indicative
of ICM. Similarly, the proportion of ICM cells was lower
in embryos retrieved from high-fat diet fed mice (Minge
et al. 2008, McPherson et al. 2015) and the number of
ICM cells was lower in embryos from overweight women
(Leary et al. 2015). CDX2+ cell numbers and proportion
were also reduced in PA-treated embryos, which is
indicative of reduced numbers of TE cells. Similarly, the
number of TE cells is reduced in embryos from overweight
women (Leary et al. 2015). Both decreased proliferation
and increased apoptosis were observed in trophoblast
stem cells cultured with PA (Jungheim et al. 2011a). The
reduction in total cell number as well as both ICM and
TE cells suggests that PA treatment promotes metabolic
changes within the early embryo (McKeegan & Sturmey
2011). Leary et al. (2015) observed reductions in glucose
uptake, alterations in amino acid turnover and increases
triglyceride storage in embryos from overweight women.
We also observed that PA treatment reduced the
fluorescent levels of Na+/K+ ATPase, E-cadherin and ZO1
properly localized to blastomere cell margins. Exposure
to high-fat diet reduced mRNA expression and reduced
assembly of tight junctions and adherens junctions as
well as Na+/K+ ATPase expression and function in corneal
cells (Bu et al. 2020). In addition, increased amounts of
PA in the lipid bilayer reduced Na+/K+ ATPase function
(Gianfrancesco et al. 2019). Na+/K+ ATPase activity is
linked to membrane fluidity and negatively associated
with levels of saturated fatty acids in erythrocytes
(Rodrigo et al. 2014). Similarly, palmitate decreased
integrity of tight and adherens junctions and increased
permeability of the gut epithelium (Ghezzal et al. 2020).
Failure to establish these junctions appropriately and
produce Na/K-ATPase activity required for establishing a
trans-trophectoderm ion gradient is likely the main factor
underlying the reduced ability of PA-treated embryos to
cavitate and form blastocysts (Barcroft et al. 1998, Betts
et al. 1998, Watson & Barcroft 2001). Furthermore,
blastocyst formation gene and cell fate promoting
gene expression are interconnected, as CDX2-deficient
embryos have deficiencies in forming and regulating
trophectoderm apical tight junctions (Strumpf et al.
2005) and ZO-1 gene knockout decreased expression of
OCT4 and CDX2 (Wang et al. 2008).
The total cell number in blastocysts and the
proportion of ICM cells are important determinants
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of embryo viability following transfer (Papaionnou &
Ebert 1995, Lane & Gardner 1997). However, a precise
cell number is not required for blastocyst formation to
occur. For example, it is possible to split embryos in
half and still observe cavitation in embryos with half
their normal cell number (Tarkowski 1959, Papaionnou
& Ebert 1995). Since early mammalian embryos have
this capacity to cavitate with significantly reduced
cell number, we were compelled to determine if
their reduced ability to cavitate was associated with
an alteration in the expression of known blastocyst
formation genes including E-cadherin, ZO-1 and Na/KATPase alpha 1 subunit genes. We have extensive
experience with these gene products and have
significantly helped with the understanding of their
essential roles in driving cavitation and thus blastocyst
formation (Barcroft et al. 1998, Betts et al. 1998,
Watson & Barcroft 2001, Violette et al. 2006). The
fluorescence signal of all three blastocyst formation
genes was significantly reduced in 48-h PA-treated
embryos. We thus conclude that overall, it is likely that
PA treatment impedes proper blastocyst formation gene
product expression, and while cell fate gene products
are properly localized in PA-treated embryos, their
reduced ability to cavitate could be due to a disruption
in normal E-cadherin, ZO-1 and Na/K-ATPase alpha
subunit expression.
In conclusion, our study has reinforced the
harmful effects of PA exposure on mouse embryo
preimplantation development. Our observations are
applicable of understanding the consequences that
obesity may impose on human preimplantation embryo
development as FFA within follicular fluid is positively
correlated with BMI (Valckx et al. 2014) and negatively
correlated with oocyte quality (Jungheim et al. 2011b).
PA and other saturated fatty acids in the Western diet
may hinder the growth of the embryo and lead to
lower conception rates. In this study, treatment of twocell preimplantation mouse embryos with 100 µM PA
significantly reduced total embryo cell number and the
numbers of YAP+, OCT4+, and CDX2+ expressing nuclei
as well as decreasing cell adhesion, tight junction and
Na+/K+ ATPase proteins in the blastomere membranes.
In contrast, OA co-treatment alleviates these effects of
PA treatment. There are many other FFAs that should
be investigated for their influence on preimplantation
development, and as progress continues in this manner,
eventual understanding of the full possible effects
of FFA exposure to early development will unfold. It
will be important to conduct further experiments that
are directed at dissecting stage-specific and treatment
time course variation effects of PA and OA treatment
on preimplantation development. Our findings offer
potential therapeutic interventions as supplementation
of embryo culture medium with OA may improve
development in obese patients with elevated PA
serum levels.
https://rep.bioscientifica.com
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